Global GAS Pharyngitis Diagnostics Market Growth (Status and Outlook) 2023-2029

Global GAS Pharyngitis Diagnostics Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “GAS Pharyngitis Diagnostics Industry Forecast” looks at past sales and reviews total world GAS Pharyngitis Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected GAS Pharyngitis Diagnostics sales for 2023 through 2029. With GAS Pharyngitis Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GAS Pharyngitis Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global GAS Pharyngitis Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GAS Pharyngitis Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GAS Pharyngitis Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GAS Pharyngitis Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GAS Pharyngitis Diagnostics.

The global GAS Pharyngitis Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for GAS Pharyngitis Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for GAS Pharyngitis Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for GAS Pharyngitis Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key GAS Pharyngitis Diagnostics players cover Quidel Corporation, BD, Abbott Laboratories, bioMérieux SA, F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc. (Danaher), Meridian Bioscience, Inc., DiaSorin S.p.A. and Sekisui Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of GAS Pharyngitis Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Rapid Test Kit
Culture Test
PCR-based Test

Segmentation by application
Physician Clinics
Diagnostic Laboratories
Hospitals

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Quidel Corporation
BD
Abbott Laboratories
bioMérieux SA
F. Hoffmann-La Roche Ltd
Beckman Coulter, Inc. (Danaher)
Meridian Bioscience, Inc.
DiaSorin S.p.A.
Sekisui Diagnostics

Please note: The report will take approximately 2 business days to prepare and deliver.